by Madaline Spencer | May 1, 2024
Michael Hayden, PhD, CEO of Prilenia, discusses recent clinical trials testing pridopidine for the treatment of amyotrophic lateral sclerosis (ALS) and Huntington’s disease. ALS, also referred to as Lou Gehrig’s disease, is a motor neuron disease...
by Madaline Spencer | Apr 25, 2024
Michael Levy, MD, PhD, Massachusetts General Hospital and Harvard Medical School, discusses neuromyelitis optica spectrum disorder (NMOSD) and the ongoing trial for a new app that can better monitor patients with NMOSD. NMOSD is an autoimmune disorder...
by Madaline Spencer | Apr 23, 2024
Tuan Vu, MD, Professor of Neurology at University of South Florida, discusses myasthenia gravis and results from the Phase 3 CHAMPION clinical trial, testing the safety and efficacy of ravulizumab. Myasthenia gravis (MG) is a chronic autoimmune...
by Madaline Spencer | Apr 12, 2024
Brahm Goldstein, MD, Vice President, Research and Development, Hematology at CSL Behring, discusses HEMGENIX, a pivotal gene therapy for hemophilia B. Hemophilia B is a bleeding disorder that slows the blood clotting process, caused by genetic changes in...
by Madaline Spencer | Apr 10, 2024
John Charlson, MD, Medical College of Wisconsin, discusses synovial sarcomas and the SPEARHEAD-1 clinical trial testing the safety and efficacy of afami-cel in this rare disease. Synovial sarcoma is a cancer that can originate from different types of...
